Interpace Biosciences Announces Contract with Lab Benefits Management Firm
In-Network Access for More Than 3 Million MembersParsippany, NJ, April 27, 2020 (GLOBE NEWSWIRE) — Interpace Biosciences (NASDAQ: IDXG) announced […]
MAG Silver Announces a $60 Million Private Placement
VANCOUVER, British Columbia, April 27, 2020 (GLOBE NEWSWIRE) — MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”) MAG is […]
Harpoon Therapeutics Doses First Patient with HPN217, a BCMA Targeting TriTAC, for Multiple Myeloma
SOUTH SAN FRANCISCO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing […]
People Corporation Announces Financial Results for the Second Quarter of Fiscal 2020
WINNIPEG, Manitoba, April 27, 2020 (GLOBE NEWSWIRE) — People Corporation (the “Company”) (TSX Venture: PEO) today announced financial results for […]
BriaCell Files Patent Application for Novel Therapeutics for Cancer
BERKELEY, Calif., and VANCOUVER, British Columbia, April 27, 2020 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) […]
Range Announces First Quarter 2020 Production and Pricing Update
FORT WORTH, Texas, April 27, 2020 (GLOBE NEWSWIRE) — RANGE RESOURCES CORPORATION (NYSE: RRC) today announced that first quarter 2020 […]
Itaú Corpbanca files 2019 Annual Report on Form 20-F
SANTIAGO, Chile, April 27, 2020 (GLOBE NEWSWIRE) — ITAÚ CORPBANCA (NYSE: ITCB; SSE: ITAUCORP) announced today that it filed its […]
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in the ADVANCE-1 Pivotal Phase 2/3 Trial in Alzheimer’s Disease Agitation
Statistically significant improvement in Alzheimer’s disease agitation, as measured by the CMAI total score compared to placebo (p=0.010, primary endpoint)Demonstrated […]
Armstrong World Industries Reports First Quarter 2020 Results
Key HighlightsNet sales of $248.7 million, up 3% versus the prior year quarterOperating income of $76.0 million, up 39% versus […]
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
RANCHO CUCAMONGA, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) (“Amphastar”), today announces that the U.S. […]
